MedTrace Logo

A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients

NCT04674150 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-16

No results posted yet for this study

Summary

This is a pilot study to evaluate the feasibility of SpellBound's AR (augmented reality)-enabled scavenger hunt use among 20 pediatric cancer patients undergoing surgery.

Conditions

  • Pediatric Cancer
  • Surgery

Interventions

DEVICE

ARISE with AR

An augmented reality game for mobile devices with AR experiences enabled

DEVICE

ARISE without AR

An augmented reality game for mobile devices with AR experiences disabled as an control

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • ALTality, Inc.

    lead INDUSTRY

Principal Investigators

  • Christina York · ALTality, Inc.

  • Juan Cata, MD · The University of Texas at Houston MD Anderson Cancer Center

  • Jamie Sinton, MD · The Texas Children's Hospital

  • Jae Eun Choi · ALTality, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2021-08-31
Completion
2021-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04674150 on ClinicalTrials.gov